The pros and cons of noninferiority trials.
Noninferiority trials comparing new treatment with an active standard control are becoming increasingly common. This article discusses relevant issues regarding their need, design, analysis and interpretation: the appropriate choice of control group, types of noninferiority trial, ethical considerations, sample size determination and potential pitfalls to consider.
Pocock
Stuart J
SJ
Medical Statistics Unit, Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT UK. stuart.pocock@lshtm.ac.uk
D002985:Clinical Protocols; D016001:Confidence Intervals; D018849:Controlled Clinical Trials as Topic / Q000941:ethics / Q000379:methods* / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D026690:Ethics, Clinical; D006801:Humans; D010919:Placebos; D012107:Research Design; D018401:Sample Size
D010919:Placebos